causal

Regulatory Validation Locks In Instrument And Consumables

Because quality control processes are often written into FDA drug approvals with exact instruments and consumables named, customers find it expensive and risky to switch, which produces recurring revenue from consumables and service.

causalpending

Speaker

Marc

Evidence Quote

“Once that happens and it's approved, it's expensive for the customer to move to a different instrument. And also there's some risks attached with that.”

Source

Agilent: Back To The Lab— Business Breakdowns
Created: 11/12/2026, 11:55:35 AM

Your notes

Loading notes...